chr5-177385797-G-A
Variant summary
Our verdict is Likely benign. Variant got -3 ACMG points: 2P and 5B. PM2BP4_StrongBS1_Supporting
The NM_003052.5(SLC34A1):c.56G>A(p.Arg19His) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000124 in 1,613,218 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R19C) has been classified as Uncertain significance.
Frequency
Consequence
NM_003052.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -3 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
SLC34A1 | NM_003052.5 | c.56G>A | p.Arg19His | missense_variant | 2/13 | ENST00000324417.6 | |
SLC34A1 | NM_001167579.2 | c.56G>A | p.Arg19His | missense_variant | 2/9 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
SLC34A1 | ENST00000324417.6 | c.56G>A | p.Arg19His | missense_variant | 2/13 | 1 | NM_003052.5 | P1 | |
SLC34A1 | ENST00000512593.5 | c.56G>A | p.Arg19His | missense_variant | 2/9 | 2 | |||
SLC34A1 | ENST00000504577.5 | c.56G>A | p.Arg19His | missense_variant | 2/4 | 4 | |||
SLC34A1 | ENST00000507685.5 | n.140G>A | non_coding_transcript_exon_variant | 2/10 | 2 |
Frequencies
GnomAD3 genomes AF: 0.0000592 AC: 9AN: 152128Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000811 AC: 20AN: 246610Hom.: 0 AF XY: 0.0000674 AC XY: 9AN XY: 133536
GnomAD4 exome AF: 0.000131 AC: 191AN: 1461090Hom.: 0 Cov.: 32 AF XY: 0.000143 AC XY: 104AN XY: 726794
GnomAD4 genome AF: 0.0000592 AC: 9AN: 152128Hom.: 0 Cov.: 32 AF XY: 0.0000807 AC XY: 6AN XY: 74318
ClinVar
Submissions by phenotype
not provided Uncertain:2
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Oct 16, 2023 | This sequence change replaces arginine, which is basic and polar, with histidine, which is basic and polar, at codon 19 of the SLC34A1 protein (p.Arg19His). This variant is present in population databases (rs765766600, gnomAD 0.02%). This variant has not been reported in the literature in individuals affected with SLC34A1-related conditions. ClinVar contains an entry for this variant (Variation ID: 1510792). Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Not Available"; PolyPhen-2: "Benign"; Align-GVGD: "Not Available". The histidine amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Uncertain significance, criteria provided, single submitter | clinical testing | Revvity Omics, Revvity | Jan 23, 2023 | - - |
Hypophosphatemic nephrolithiasis/osteoporosis 1 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Johns Hopkins Genomics, Johns Hopkins University | Jun 08, 2023 | This SLC34A1 missense variant (rs765766600) is rare (<0.1%) in a large population dataset (gnomAD v2.1.1: 23/277936 total alleles; 0.0083%; no homozygotes). It has been reported in ClinVar (Variation ID 1510792), but has not been reported in the literature, to our knowledge. Two bioinformatic tools queried predict that this substitution would be tolerated, but these algorithms have low specificity, especially for predicting gain of function or dominant negative variants. The arginine residue at this position is evolutionarily conserved across many of the species assessed, but some species have a different amino acid at this position including four with histidine. We consider the clinical significance of c.56G>A in SLC34A1 to be uncertain at this time. - |
Inborn genetic diseases Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | May 18, 2022 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at